Navigation Links
Varian, Inc. Acquires Oxford Diffraction, Ltd.
Date:4/6/2008

PALO ALTO, Calif., April 7, 2008 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today that it has acquired Oxford Diffraction, Ltd., a privately owned company based in Abingdon, U.K. Oxford Diffraction is a leader in x-ray crystallography, an analytical technique used by scientists in pharmaceutical research and other research laboratories to determine the structure of both small molecules and large molecules such as proteins.

For crystalline compounds, x-ray crystallography is the most powerful technique available for structural analysis. Nuclear magnetic resonance (NMR) provides complementary structural information for compounds in the solid state and also structural information for compounds in solutions.

"The acquisition of Oxford Diffraction is key to Varian's goal of broadening its range of information-rich detection products for life science research," said Garry W. Rogerson, President and CEO, Varian, Inc. "Oxford Diffraction has experienced rapid growth since its formation in 2001 and has established a strong reputation in single crystal X-ray crystallography, particularly in Europe. Oxford Diffraction products will now be distributed on a global basis via Varian's worldwide distribution network."

"In addition to the obvious benefit to our business of a much larger distribution and support organization, the sale of Oxford Diffraction to Varian brings a number of additional important advantages," said Paul Loeffen CEO of Oxford Diffraction. "We now have the opportunity to offer customers more powerful solutions through combinations of complementary information-rich techniques to include X-ray crystallography, nuclear magnetic resonance (NMR) spectrometry and liquid chromatography-mass spectrometry (LC-MS). Furthermore, as part of Varian, we look forward to continuing the development of innovative technologies and products for our customers."

"Existing Oxford Diffraction customers will continue to benefit
'/>"/>

SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
2. Varian, Inc. Offers New Products for the Rapid Purification of Synthetic Oligonucleotides.
3. Varian, Inc. Acquires Analogix Business
4. Varian, Inc. CEO to Speak at JPMorgan Healthcare Conference
5. Varian, Inc. Board Authorizes New $100 Million Stock Repurchase Program
6. New High Performance Gas Chromatographs and Analysis Solutions From Varian, Inc. Offer Enhanced Performance and Capabilities for More Applications
7. New Ion Trap Mass Spectrometers From Varian, Inc. Offer the Ultimate in Sensitive Detection and High Productivity
8. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
9. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
10. Food Bank For New York City Acquires FoodChange
11. Concentra Acquires Assets of Renew Health & Wellness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2008)... Open enrollment is now h...s cover expenses not covered by Medicare, and may ...any consumers are now shopping online for instant ... Fort Collins, CO (PRWEB) November 21, 2008 -- Me...ent for Medicare Supplement plans . Medicare Adv...
(Date:11/21/2008)...Finding may lead to new therapies for preterm labo...- Researchers say they,ve found the switch that ac... childbirth, a finding that may lead to therapies ... normally binds the protein IP on the surface of t... inactive during pregnancy. , But researchers ...
(Date:11/21/2008)..., TALLAHASSEE, Fla. -- A Florida State Universit...g Wang has discovered an important new layer of re...ead to a greater understanding of the way cancer b...cal sciences at the College of Medicine, said the ...ose cancer and could lead to the design of new dru...
(Date:11/21/2008)...LOVELAND, Colo., Nov. 21 ...ced it will present at the New York Society of,Se... Pharma Conference on,December 2, 2008 at 1177 Av...The presentation is scheduled to begin at 9:35 a.m... be available via live webcast and for two weeks,...
Breaking Medicine News(10 mins):Health News:MediGap Advisors Announces Open Enrollment for Medicare Supplement Plans 2
...pical cyclone Glenda has increased the spread of t...y Valley encephalitis// (MVE), in Western Australi... wet season in Kimberley has spread the virus that.... The cyclone Glenda along with the more recent cy...
...earcher, Professor Ian Frazer of the University of... Premier's Fellowship. The prestigious Fellowship ...r award for his work in developing a vaccine for c...ellowship, Professor Ian Frazer will get $250,000 ...
...eo game makers are now looking to extend their rea...tele is concerned. And a really ripe market awaits... to "Brain Train" concept like a duck to water.// ...s sold 3.3 million of its "Brain Training for Adul...
...ording to a senior Guangdong health official of Ch...this year's peak human bird flu season in the prov...de by other health specialists. The senior health...rector of the Guangdong Centre for Disease Control...
Other Medicine News:
(Date:11/19/2008)...e/ -- Biotech scientists increasingly are applying...etter understand the effects of novel drug candida...c Engineering & Biotechnology News ( GEN ). T...w compound,s mechanism of action and eventually de...ing to the November 15 issue of GEN . ( http://ww...
(Date:11/18/2008)...n more, make a donation or send a Christmas Seals ...USNewswire/ -- Millions will receive Christmas Sea...n Lung Association. These decorative holiday stamp...ng back to 1907 when the Lung Association led effo...ericans alive today have no vivid memories of how ...
(Date:11/18/2008)...gnosed, elderly AML patients , , PRINCETON,...cals today announced that the first patient has be...of CPX-351 (Cytarabine:Daunorubicin) Liposome Inje...id leukemia (AML). , , The first patient wa...al College of Cornell University and New York Pre...
(Date:11/12/2008)...wswire/ -- A new study being,published in this Fri...question, what causes Parkinson,s disease?, One o...rch into,Parkinson,s disease is what causes the se...ce. Answering this question has been especially di...es of brain cells that produce,dopamine and they a...
Breaking Medicine Technology:GEN Reports on the Trend Toward Predictive Toxicogenomics 2American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3A Window Into Parkinson's Disease 2LaVoie Group Adds Cancer Therapeutics Company Neotropix 28R 29 to Its Life Science Agency Roster 26846 1LaVoie Group Adds Cancer Therapeutics Company Neotropix 28R 29 to Its Life Science Agency Roster 26846 2Covance Decides to Pursue Its Original Preclinical Strategy in China 7954 1Covance Decides to Pursue Its Original Preclinical Strategy in China 7954 2Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 1Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 2Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 3Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 4Austin Dentistry Clinic Now Offers Certified Full Service Sedation Dentistry All Gain No Pain 26841 1Austin Dentistry Clinic Now Offers Certified Full Service Sedation Dentistry All Gain No Pain 26841 2
...ot Study Demonstrates 50% Survival in Valortim-Tre..., March 29, 2007,/PRNewswire-FirstCall/ -- Medarex...d PharmAthene, Inc., a privately held,biotechnolog...se,countermeasures, today announced that Valortim(...didate being developed for the,prevention and trea...
...trations Reached in Key Lung Compartments, REINACH...e-FirstCall/ -- Arpida Ltd. today announced promis... These radiolabelled,Human Microdose studies inclu...groundbreaking study is the first ever using Micro...s in lung compartments.,The results showed that AR...
Other Medicine Technology:Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 8Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 2Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 3Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 5
Low-profile, hand-held instrument.
Low-profile, hand-held instrument.
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries.
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries.
Medicine Products: